Stockyfly One Page Analysis | Buy Stocks today

16/06/2025

Jubilant Pharmova Ltd

BSE: 530019 NSE: JUBLPHARMA

Pharmaceuticals

Financial Health Score: 56%

About the Company

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.

Pros

Company has been maintaining a healthy dividend payout of 275%

Cons

Stock is trading at 7.74 times its book value
The company has delivered a poor sales growth of -25.0% over past five years.
Company has a low return on equity of 1.49% over last 3 years.
Earnings include an other income of Rs.88.4 Cr.

Stock PE: 732

ROCE: 2.9

Market Cap: 17944 Cr.

Book Value: 146

ROE: 1.04

Face Value: 1

Credit Report: View PDF

JUBLPHARMA - Price Chart

Volume Chart

Last 30 Days Bulk Deals

SL#	Symbol	Name	Date	Client	Buy/Sell	Quantity	Price	Remark
1	JUBLPHARMA	Jubilant Pharmova Ltd	13/06/2025	NIKITA RESOURCES PRIVATE LIMITED	SELL	1,962,434	1,060	-
2	JUBLPHARMA	Jubilant Pharmova Ltd	13/06/2025	JUBILANT ENPRO PRIVATE LIMITED	SELL	2,116,000	1,060	-
3	JUBLPHARMA	Jubilant Pharmova Ltd	13/06/2025	KOTAK MAHINDRA MUTUAL FUND	BUY	1,693,434	1,060	-
4	JUBLPHARMA	Jubilant Pharmova Ltd	13/06/2025	KOTAK FUNDS - INDIA MIDCAP FUND	BUY	1,593,500	1,060	-
SL#	Symbol	Name	Date	Client	Buy/Sell	Quantity	Price	Remark

Technical Indicators

Today's OPEN >= LOW and HIGH=CLOSE	No
Is a 7 Days Breakout ?	No
3 Days Consecutive Volume Spike:	No
2 Days Consecutive Price Hike:	Yes
Above 20 MA ?	Above
Above 50 MA ?	Above
Above 100 MA ?	Above
Above 200 MA ?	Above

Important Disclaimer

One Page Analysis is calculated on the basis of Technical factors. No News or Result-oriented factors were considered.

This is a free tool only to help traders on a technical basis.

* Consult your financial advisor before investing in a strong market as it is subject to high risk.

One Page Analysis